📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
395 analysed today
FollowTelegram
395
Today
149,796
All-time analysed
42,945
Positive
6,666
Negative
91,495
Neutral
8,622
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
210 announcements match the current filters (relevance ≥ 5).
Medi Assist Expands to Southeast Asia via Strategic AI-Tech Partnership with LawtonAsia
Medi Assist Healthcare Services has entered a strategic partnership with Thailand-based LawtonAsia to deploy its AI-powered health-tech platform in Southeast Asia. This collaboration allows LawtonAsia to use Medi Assist's proprietary systems for medical insurance claims management and flexible benefit plans. The move aligns with Medi Assist's global expansion strategy, leveraging its technology stack to serve international markets. Implementation is currently underway in Thailand, with a full launch expected within the coming weeks.
Key Highlights
Strategic partnership with LawtonAsia to bring AI-driven health-tech to the Thailand market.
Deployment of proprietary platform to streamline claims processing and enhance transparency.
Enables corporate clients to manage flexible benefit plans within insurance programs.
Implementation phase has commenced with a full 'go-live' expected in the coming weeks.
👀 What to Watch
Investors should monitor the successful execution of this partnership as it demonstrates the scalability of Medi Assist's tech platform beyond India. Positive outcomes could lead to further international contracts and improved margins.
Medi Assist Shareholders Approve Re-appointment of CEO and Chairman for 5-Year Terms
Medi Assist Healthcare Services Limited has announced the successful passage of five key resolutions via postal ballot with overwhelming shareholder support. Dr. Vikram Jit Singh Chhatwal has been re-appointed as Chairman and Whole-Time Director for a five-year term starting March 1, 2026, with 98.64% votes in favor. Similarly, Mr. Satish V N Gidugu was re-appointed as CEO and Whole-Time Director for five years with 99.61% approval. The resolutions also secured the re-appointment of an Independent Director and approved executive remuneration for the next three years.
Key Highlights
Dr. Vikram Jit Singh Chhatwal re-appointed as Chairman and WTD for 5 years with 98.64% votes in favor
Mr. Satish V N Gidugu re-appointed as CEO and WTD for 5 years with 99.61% votes in favor
Dr. Ritu Niraj Anand re-appointed as Independent Director for a second 5-year term with 99.99% approval
Executive remuneration for both the Chairman and CEO approved for a 3-year period effective March 1, 2026
Total of 53,523,094 votes were polled across institutional and non-institutional categories
👀 What to Watch
Investors should view this as a positive sign of leadership stability and continuity in the company's strategic direction. The high approval ratings indicate strong institutional confidence in the current management team.
Persistent Systems Clarifies No Imminent M&A Transaction Amid Market Speculation
Persistent Systems has issued a formal statement to address recent market rumors regarding potential merger and acquisition activities. The company confirmed that while it continuously evaluates inorganic growth opportunities as part of its strategy, no transaction has reached the stage requiring disclosure under SEBI regulations. This clarification aims to manage investor expectations and reduce volatility caused by unverified reports. The company maintains a governance-oriented approach, promising transparent disclosure if any proposal matures.
Key Highlights
Persistent Systems addresses market speculation regarding potential M&A opportunities
Company states no imminent transaction currently requires disclosure under SEBI Regulation 30
Management confirms that exploring inorganic growth remains a core part of their business strategy
The company emphasizes its commitment to transparent disclosure and governance standards
👀 What to Watch
Investors should treat recent rumors with caution and rely only on official company disclosures for investment decisions. The stock may see some cooling of speculative interest following this clarification.
GST Department Initiates Search at Medi Assist TPA's Mumbai Office
The Department of Goods and Services Tax, Maharashtra, has initiated a search operation at the Mumbai office of Medi Assist Insurance TPA Private Limited, a material wholly-owned subsidiary of Medi Assist Healthcare Services. The search, conducted under Section 67 of the CGST Act, 2017, commenced on February 16, 2026. While the company claims that business operations remain unaffected and no immediate financial impact is anticipated, the proceedings are currently ongoing. Investors should remain cautious as the final outcome regarding potential tax liabilities or penalties is yet to be determined.
Key Highlights
Search operation initiated by Maharashtra GST Department at the Mumbai office of Medi Assist Insurance TPA Private Limited.
Action taken under Section 67 of the Central Goods and Service Tax Act, 2017, starting February 16, 2026.
The target entity is a material wholly-owned subsidiary of the listed parent company.
Management states that business operations are currently unaffected and no financial impact is expected at this stage.
👀 What to Watch
Investors should monitor subsequent filings for any quantification of tax demands or penalties resulting from this search. Maintain a watch on the stock as regulatory actions on material subsidiaries can lead to short-term volatility.
Medi Assist Q3 FY26: Consolidated Revenue Up 29.9%, Company Becomes Debt-Free
Medi Assist Healthcare Services reported a robust Q3 FY26 with consolidated total income rising 29.9% YoY, significantly aided by the Paramount acquisition. The company successfully transitioned to a debt-free status in January 2026, having reduced debt from INR 243 crores in September 2025. Operational efficiency improved as Paramount's standalone margins expanded by 557 bps QoQ, while tech-driven fraud prevention (MAven Guard) saved INR 400 crores. The group market share reached a significant 32.2%, reflecting strong organic and inorganic growth.
Key Highlights
Consolidated total income grew 29.9% YoY in Q3 FY26, with 9M FY26 income up 23.5% to INR 128.9 crores.
Achieved debt-free status in January 2026, down from a debt of INR 243 crores in September 2025.
Group market share increased to 32.2%, representing a 307 bps year-on-year improvement.
Technology revenues surged 81.5% YoY, with the MAven Guard platform preventing INR 400 crores in fraud.
Paramount integration is on track with a slump transfer of business effective February 1, 2026.
👀 What to Watch
Investors should take note of the rapid deleveraging and successful integration of Paramount which is driving margin expansion. The strong growth in high-margin tech-led revenues and dominant market share in the group segment makes it a compelling play in the TPA space.
CARE Reaffirms Medi Assist Rating at 'AA-; Stable'; Company Repays Entire ₹150 Cr Bridge Debt
CARE Ratings has reaffirmed Medi Assist's long-term rating at 'CARE AA-; Stable', reflecting its dominant 21.3% market share in the TPA industry. The company has successfully repaid its entire ₹150 crore bridge debt used for the ₹412 crore Paramount TPA acquisition, returning to a net debt-free status as of January 2026. Financial performance remains strong with Premiums Under Management (PUM) expected to reach ₹26,500 crore in FY26, supported by a 94% corporate retention rate. While integration of new acquisitions slightly compressed H1FY26 margins to 19.3%, profitability is expected to recover to the 21-22% range in the medium term.
Key Highlights
CARE AA-; Stable and CARE A1+ ratings reaffirmed for bank facilities totaling ₹16 crore.
Successfully repaid ₹150 crore bridge debt by January 15, 2026, following a ₹198 crore preferential issue.
Market share in group insurance segment increased to 32.2% as of September 2025.
PUM projected to grow to ₹26,500 crore in FY26, up from ₹21,108 crore in FY25.
Maintains a robust network of over 20,000 hospitals and 10,500 corporate clients with 94% retention.
👀 What to Watch
Investors should take confidence in the company's ability to fund large acquisitions (Paramount TPA) and quickly return to a debt-free status. The reaffirmation of high credit ratings and dominant market share positions the company well for long-term growth in the health insurance sector.
Medi Assist Credit Rating Reaffirmed at CARE AA-; Stable; Company Now Debt-Free
CARE Ratings has reaffirmed Medi Assist's credit rating at 'CARE AA-; Stable' for long-term and 'CARE A1+' for short-term facilities. The company has successfully integrated the ₹412 crore Paramount TPA acquisition and repaid its entire external debt of ₹150 crore as of January 2026. With a market share of 21.3% in the TPA industry, the company expects revenue growth of 27-28% in FY26. Despite a temporary dip in H1FY26 margins to 19.32%, synergy benefits are expected to restore margins to 21-22% in the medium term.
Key Highlights
CARE Ratings reaffirmed 'CARE AA-; Stable' and 'CARE A1+' ratings for bank facilities totaling ₹16 crore.
Company is now debt-free after repaying ₹150 crore bridge debt used for the Paramount TPA acquisition.
Market share in the overall health TPA industry rose to 21.3% following strategic acquisitions.
Revenue growth is projected at 27-28% for FY26, driven by higher Premiums Under Management (PUM).
Preferential issue of ₹198 crore in October 2025 significantly strengthened the balance sheet and liquidity.
👀 What to Watch
The reaffirmation and debt-free status confirm strong financial management after a large acquisition. Investors should monitor the company's ability to maintain its 20%+ operating margins while scaling its market share.
Persistent Named Fastest Growing Global IT Services Brand; Brand Value Up 22% to $989M
Persistent Systems has been recognized as the fastest-growing IT services brand globally in the 2026 Brand Finance IT Services 25 report. The company's brand value increased by 22% year-on-year, rising from $811 million in 2025 to $989 million in 2026. This recognition is backed by 23 sequential quarters of revenue growth and a total brand value surge of 468% since 2020. The company now ranks as the 12th strongest IT services brand globally with an improved Brand Strength Index of 75.8.
Key Highlights
Brand value increased 22% year-on-year to $989 million in 2026.
Ranked as the 12th strongest IT Services brand globally with an AA+ rating.
Achieved 468% growth in brand value since 2020, the highest in its category.
Maintained 23 sequential quarters of revenue growth leading up to the recognition.
Brand Strength Index (BSI) improved from 74.8 to 75.8.
👀 What to Watch
This recognition underscores Persistent's successful transition into a large-scale enterprise transformation partner and its growing competitive moat in AI-led services. Investors should monitor if this enhanced brand equity translates into higher win rates for large-scale digital engineering contracts.
Medi Assist Q3 FY26: Revenue Up 30%, Debt-Free Status Achieved, Paramount Integration on Track
Medi Assist reported a strong Q3 FY26 with consolidated revenue growing 29.9% YoY to ₹247.2 Cr, driven by the Paramount acquisition and organic growth. The company successfully transitioned to a debt-free status in January 2026 after significantly reducing debt from ₹243.4 Cr in September 2025. Operational efficiency improved with consolidated EBITDA margins expanding 154 bps QoQ to 18.6%, while Paramount's standalone margins saw a significant 557 bps QoQ jump. Market share in the group segment reached 32.2%, and technology-led revenue surged 81.5% YoY, highlighting the scalability of its AI-powered platform.
Key Highlights
Consolidated Total Income grew 29.9% YoY to ₹247.2 Cr in Q3 FY26.
Achieved debt-free status in January 2026, down from ₹243.4 Cr debt in September 2025.
Group market share expanded to 32.2%, with total premiums under management reaching ₹19,289.1 Cr.
Technology segment revenue grew 81.5% YoY; MAven Guard identified ~₹400 Cr in fraud savings.
Paramount TPA business slump transfer to Medi Assist TPA approved, effective February 1, 2026.
👀 What to Watch
Investors should view the rapid debt reduction and margin expansion at Paramount as strong positive signals for future profitability. The stock remains a key play on the growing health insurance penetration in India through a scalable, tech-led TPA model.
Medi Assist Q3 FY26: 24% Revenue Growth, Becomes Debt-Free with 32.2% Group Market Share
Medi Assist reported a robust 24% YoY revenue growth for 9M FY26, driven by a 21.9% increase in premiums administered to INR 19,298.1 Cr. The company achieved a significant milestone by becoming debt-free in January 2026, supported by a healthy free cash balance of INR 200.1 Cr. Market share in the critical Group segment expanded by 307 bps to 32.2%, while technology-led revenues surged by 81.5% YoY. The integration of Paramount TPA is on track with the business transfer effective from February 1, 2026.
Key Highlights
Operating revenue grew 24% YoY for 9M FY26, with adjusted PAT reaching INR 46.3 Cr.
Company became debt-free from January 2026, reducing debt from INR 39.4 Cr in Dec '25.
Group market share expanded by 307 bps YoY to 32.2%, with total premiums reaching INR 19,298.1 Cr.
Technology-driven revenues grew 81.5% YoY, with AI-powered fraud detection flagging INR 400 Cr in potential fraud.
Paramount TPA integration finalized with business transfer effective Feb 1, 2026, and tech migration complete.
👀 What to Watch
Investors should view the debt-free status and significant market share gains as strong indicators of operational efficiency and competitive dominance. The successful integration of Paramount TPA and surge in high-margin tech revenue suggest potential for further margin expansion.
Medi Assist Reports Zero Deviation in Utilization of ₹198 Cr Raised via Preferential Issue
Medi Assist Healthcare Services has confirmed zero deviation in the utilization of ₹198.00 crore raised through a preferential issue in October 2025. As of December 31, 2025, the company has successfully utilized ₹148.40 crore primarily for debt prepayment and repayment in its material subsidiary, Medi Assist Insurance TPA Pvt. Ltd. The remaining ₹49.60 crore is currently parked in liquid mutual funds and bank balances, intended for general corporate purposes. The monitoring agency, CARE Ratings, has verified the deployment and reported no concerns or variations from the original objects.
Key Highlights
Total funds raised via preferential issue amounted to ₹198.00 crore on October 10, 2025.
₹148.40 crore utilized for debt repayment in subsidiary, meeting 98.9% of the specific allocation for that object.
Zero deviation reported in the utilization of funds compared to the objects stated in the offer document.
Unutilized proceeds of ₹49.60 crore are safely deployed in liquid mutual funds across four major AMCs.
CARE Ratings Limited, acting as the Monitoring Agency, confirmed all utilizations align with the EGM resolution.
👀 What to Watch
Investors should take confidence in the company's transparent capital allocation and adherence to stated timelines for debt reduction. The successful deployment of funds for subsidiary debt repayment is expected to strengthen the consolidated balance sheet.
Medi Assist to Merge Subsidiaries IHMS and MCSI to Streamline Operations
Medi Assist Healthcare Services has approved the merger of its two wholly-owned subsidiaries, International Healthcare Management Services (IHMS) and Mayfair Consultancy Services India (MCSI). As of March 31, 2025, IHMS reported a turnover of Rs. 72.68 million, while MCSI reported Rs. 48.50 million. The merger is an internal restructuring aimed at consolidating back-office and consultancy services to achieve operational synergies and reduce administrative overheads. There is no cash consideration involved, and the parent company's shareholding pattern remains unchanged.
Key Highlights
Amalgamation of IHMS (Transferor) into MCSI (Transferee), both 100% owned subsidiaries.
IHMS FY25 turnover stood at Rs. 72.68 million with a net worth of Rs. 52.82 million.
MCSI FY25 turnover stood at Rs. 48.50 million with a net worth of Rs. 52.08 million.
No cash consideration or change in the shareholding pattern of Medi Assist Healthcare Services Limited.
Expected benefits include cost savings, rationalization of resources, and simplified regulatory compliance.
👀 What to Watch
This is a routine internal restructuring to improve corporate efficiency and reduce costs. Investors should view this as a minor positive for long-term operational streamlining, though it has no immediate impact on the stock's valuation.
Medi Assist to Integrate Paramount TPA via Slump Sale and Merger
Medi Assist Healthcare has approved a three-step integration plan for Paramount TPA, which it acquired in July 2025. The process involves a slump transfer of the TPA business to Medi Assist TPA effective February 1, 2026, followed by the surrender of Paramount's license and a final merger of the residual entity into the parent company. This restructuring is designed to comply with IRDAI regulations and achieve operational efficiencies by consolidating two licensed entities. Paramount TPA reported a standalone turnover of ₹1,785.70 million and a net worth of ₹993.46 million for FY25.
Key Highlights
Slump transfer of Paramount TPA's business to Medi Assist TPA effective February 1, 2026, for nil consideration.
Paramount TPA recorded a turnover of ₹1,785.70 million and net worth of ₹993.46 million as of March 31, 2025.
Final merger of residual Paramount entity into the listed parent company with an appointed date of July 1, 2025.
Integration aims to achieve economies of scale and centralized treasury management of surplus funds.
No change in the shareholding pattern of the listed entity (Medi Assist Healthcare) post-merger.
👀 What to Watch
Investors should view this as a positive move to simplify the corporate structure and realize synergies from the Paramount acquisition. Monitor the progress of the IRDAI license surrender and the final NCLT merger approval.
Medi Assist to Integrate Paramount TPA via Slump Sale and Merger
Medi Assist Healthcare Services is executing a three-step integration of Paramount TPA, which it acquired in July 2025. The process involves a slump transfer of the TPA business to its subsidiary, Medi Assist TPA, followed by the surrender of Paramount's license and a final merger of the residual entity into the parent company. This restructuring is designed to comply with IRDAI regulations and consolidate treasury assets under the listed parent entity. No new shares will be issued as Paramount is a wholly-owned step-down subsidiary, ensuring no equity dilution.
Key Highlights
Slump transfer of Paramount TPA business to Medi Assist TPA effective February 1, 2026, for nil consideration.
Paramount TPA reported a standalone turnover of ₹1,785.70 million and net worth of ₹993.46 million as of March 31, 2025.
The merger appointed date is fixed as July 1, 2025, to facilitate consolidation of treasury and accounts.
Restructuring aims to achieve economies of scale and reduce administrative costs through a simplified corporate structure.
Integration fulfills IRDAI's condition to operate under a single TPA license post-acquisition.
👀 What to Watch
Investors should view this as a positive move toward operational synergy and regulatory compliance. The consolidation of treasury assets at the parent level enhances corporate governance and capital allocation efficiency.
Medi Assist to Restructure Paramount TPA via Slump Sale and Merger for Operational Efficiency
Medi Assist Healthcare Services has approved a three-step integration plan for Paramount TPA, a subsidiary acquired in July 2025. The plan involves a slump transfer of the TPA business to Medi Assist TPA for nil consideration, followed by the surrender of Paramount's regulatory license. Finally, the residual entity, which holds treasury assets and reported an FY25 standalone turnover of ₹1,785.70 million, will be merged into the listed parent company to centralize capital management.
Key Highlights
Slump transfer of Paramount TPA's business to Medi Assist TPA effective February 1, 2026, for nil consideration.
Paramount TPA reported a standalone turnover of ₹1,785.70 million and net worth of ₹993.46 million for FY25.
The merger of the residual entity into the parent company has an appointed date of July 1, 2025, for consolidation purposes.
Restructuring fulfills IRDAI mandates to integrate licensed TPA businesses post-acquisition into a single entity.
No change in the shareholding pattern of the listed entity as the target is a wholly-owned step-down subsidiary.
👀 What to Watch
Investors should view this as a positive move to simplify corporate structure and reduce administrative overheads. The consolidation of treasury assets at the parent level should improve capital allocation and corporate governance.
Medi Assist Approves Q3 Results, Paramount TPA Integration Plan, and Promoter Reclassification
Medi Assist Healthcare Services has approved its Q3 FY26 financial results and a comprehensive restructuring plan to integrate Paramount Health Services. The integration involves a three-step process: a slump sale of the TPA business, surrender of the TPA license, and an eventual merger with the parent company with an appointed date of July 1, 2025. Additionally, the board approved the reclassification of Bessemer India Capital and five other entities from 'Promoter' to 'Public' as they now hold zero shares. Senior management changes were also noted, including the resignation of the Chief Innovation and Operations Officer.
Key Highlights
Approved a 3-step integration of Paramount TPA involving a slump sale to Medi Assist TPA and a final merger with the parent company.
Reclassified 6 entities including Bessemer India Capital Holdings II Ltd from 'Promoter' to 'Public' category as they hold 0% equity.
Chief Innovation and Operations Officer Himanshu Rastogi resigned effective February 06, 2026, due to personal reasons.
Approved the amalgamation of wholly-owned subsidiaries IHMS and MCSI to streamline corporate structure.
Appointed Ms. Sunita Rebecca Cherian as an Additional Director (Non-Executive, Non-Independent) effective February 06, 2026.
👀 What to Watch
Investors should monitor the execution of the Paramount TPA integration which aims to streamline operations and realize synergies. The promoter reclassification marks the formal exit of private equity investors, which is a typical post-listing evolution for the company.
Medi Assist Q3 Revenue Up 29% YoY to ₹2,397 Mn; Net Profit Drops 86% on Exceptional Items
Medi Assist Healthcare reported a 28.9% YoY increase in revenue from operations to ₹2,396.71 million for Q3 FY26. However, consolidated Net Profit fell sharply by 86.2% YoY to ₹41.36 million, primarily due to an exceptional item of ₹141.99 million and significantly higher finance and depreciation costs following the Paramount acquisition. The company also disclosed a search and seizure operation by the Directorate of Enforcement (ED) at a subsidiary's office, which auditors highlighted as an 'Emphasis of Matter'. For the nine-month period, PAT stood at ₹348.34 million, down from ₹699.30 million in the previous year.
Key Highlights
Revenue from operations grew 28.9% YoY to ₹2,396.71 million in Q3 FY26.
Net Profit (PAT) crashed 86.2% YoY to ₹41.36 million from ₹299.74 million in the year-ago quarter.
Finance costs rose sharply to ₹83.89 million from ₹24.93 million YoY, reflecting acquisition-related debt/liabilities.
An exceptional item of ₹141.99 million was recognized in Q3 FY26, impacting the bottom line.
Auditors flagged an ongoing ED search and seizure operation at a wholly-owned subsidiary as an Emphasis of Matter.
👀 What to Watch
Investors should exercise caution as the significant profit decline and regulatory scrutiny from the ED investigation outweigh the healthy revenue growth. Monitor management's commentary on the exceptional items and the timeline for margin recovery post-acquisition integration.
SIS Ltd Q3 FY26: Revenue Crosses INR 4,000 Cr Milestone; INR 290 Cr One-Time Provision Taken
SIS Limited reported a record-breaking quarter with consolidated revenue reaching INR 4,185 crores, a 24.5% YoY increase. While operating EBITDA grew 25.2% to INR 196 crores, the company recognized a significant one-time exceptional charge of INR 290 crores for prior-period gratuity and leave liabilities due to new Labor Code definitions. Management has opted for a conservative accounting approach and intends to recover these costs from clients as pass-throughs once rules are notified. Additionally, the company announced a dividend of INR 7 per share, signaling a shift toward a balanced shareholder return policy including both dividends and buybacks.
Key Highlights
Consolidated revenue grew 24.5% YoY to INR 4,185 crores, with organic growth standing at 15%.
India Security segment revenue surged 33.7% YoY to INR 1,898 crores, while International Security grew 20.8%.
One-time exceptional provision of INR 290 crores taken for Labor Code-related gratuity liabilities, impacting reported PAT.
Return on Capital Employed (ROCE) improved significantly to 15.2% from 12% in the previous year.
Days Sales Outstanding (DSO) improved to 67 days from 69 days in the previous quarter.
👀 What to Watch
Investors should view the INR 290 crore provision as a conservative accounting measure that could lead to future P&L write-backs as client recoveries materialize. The underlying operational momentum and improving ROCE suggest the company is on a strong recovery path.
SIS Ltd Q3 FY26: Record Revenue of ₹4,185 Cr; ₹290 Cr One-time Labor Code Provision Taken
SIS reported its highest-ever quarterly revenue of ₹4,185 crore, marking a 24.5% YoY growth driven by strong performance across all business segments. The company took a conservative one-time exceptional charge of ₹290 crore related to prior-period gratuity liabilities under new Labor Codes, which impacted reported profits but cleaned up the balance sheet. Operating EBITDA grew 25.2% YoY to ₹196 crore, while ROCE improved significantly to 15.2%. Management announced a dividend of ₹7 per share and hinted at a potential buyback in the second half of the year.
Key Highlights
Consolidated revenue crossed ₹4,000 Cr for the first time, reaching ₹4,185 Cr (+24.5% YoY).
India Security segment grew 33.7% YoY to ₹1,898 Cr; FM segment EBITDA grew 29.1% YoY.
Recognized a one-time ₹290 Cr exceptional charge for gratuity liabilities to ensure long-term financial prudence.
Return on Capital Employed (ROCE) rose to 15.2% from 12% a year ago.
Announced a dividend of ₹7 per share with a potential buyback planned for H2 FY26.
👀 What to Watch
Investors should view the ₹290 crore provision as a prudent balance sheet cleanup that paves the way for cleaner future earnings. The strong revenue growth and improving ROCE suggest a robust recovery, making it a good time to hold or accumulate on dips.
SIS Q3 FY26 Revenue Crosses ₹4,000 Cr; One-time ₹290 Cr Labour Code Charge Hits Net Profit
SIS Limited reported a strong topline growth of 24.5% YoY, with quarterly revenue exceeding INR 4,185.2 crore for the first time. Operating EBITDA grew 25.2% YoY to INR 196.3 crore, reflecting robust performance across India and International security segments. However, the company took a significant one-time exceptional charge of INR 290 crore due to the implementation of new Labour Codes, leading to a reported net loss of INR 138.4 crore. Despite this accounting hit, management views the labour reforms as a long-term structural tailwind for organized players.
Key Highlights
Consolidated revenue grew 24.5% YoY to INR 4,185.2 crore, surpassing the INR 4,000 crore quarterly milestone.
Operating EBITDA increased 25.2% YoY to INR 196.3 crore with an operating margin of 4.7%.
Reported a net loss of INR 138.4 crore after a one-time INR 290 crore provision for gratuity and service costs under new Labour Codes.
Security Solutions India segment revenue jumped 33.7% YoY to INR 1,898 crore, driven by new order wins.
SIS-Prosegur has filed its Draft Red Herring Prospectus (DRHP) with SEBI for a proposed IPO.
👀 What to Watch
Investors should focus on the strong operational growth and the 'Operating PAT' of INR 100.8 crore rather than the reported loss, which is due to a non-recurring regulatory adjustment. The upcoming SIS-Prosegur IPO remains a significant potential catalyst for value unlocking.
